Partner Headlines - CLVS

  1. Morning Market Losers

    Benzinga
  2. Clovis Oncology Enters Into Oncology Clinical Trial Collaboration ...

    Benzinga
  3. UPDATE: Stifel Reiterates On Clovis Oncology Following 3Q14 LPS

    Benzinga
  4. Morning Market Losers

    Benzinga
  5. Biotech Enters Reporting Season With Large Caps Central To Sector ...

    Benzinga
  6. US Stock Futures Flat Ahead Of Manufacturing PMI

    Benzinga
  7. Market Wrap For June 5: Markets Positive Before Friday's Employment ...

    Benzinga
  8. UPDATE: Stifel Upgrades Clovis Oncology On Favorable Risk/Reward

    Benzinga
  9. Market Wrap For June 4: Markets Slightly Higher On Light Volume, ...

    Benzinga
  10. Citi Downgrades Clovis, Rates It As High Risk

    Benzinga
  11. Benzinga's Volume Movers

    Benzinga
  12. Benzinga's Top #PreMarket Gainers

    Benzinga
  13. UPDATE: Clovis Oncology Shares Rise 12% Premarket on Positive ...

    Benzinga
  14. US Stock Futures Rise; GDP, Jobless Claims Data In Focus

    Benzinga
  15. Mid-Morning Market Update: Markets Open Higher; Francesca's Issues ...

    Benzinga
  16. Benzinga's Top Initiations

    Benzinga
  17. Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam ...

    Benzinga
  18. Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers ...

    Benzinga
  19. Benzinga's Top #PreMarket Gainers

    Benzinga
  20. Clovis Oncology Announces 2014 Objectives, Financial Guidance ...

    Benzinga
  21. What The Top Stocks Of 2013 Had In Common

    IBD
  22. Clovis Oncology CO-1686 Clinical Data Accepted as Oral Presentation ...

    Benzinga
  23. Clovis Oncology Announces 2M Share Offering by Selling Stockholders ...

    Benzinga
  24. Benzinga's M&A Chatter for Tuesday November 19, 2013

    Benzinga
  25. Why Clovis Oncology Was The Short Trade Of The Day

    Benzinga
  26. UPDATE: H.C. Wainwright nitiates on Clovis Oncology On Prospects ...

    Benzinga
  27. Mid-Morning Market Update: Markets Mixed; Merck Profit Beats ...

    Benzinga
  28. Clovis Oncology's CO-1686 Demonstrates Promising Clinical Activity ...

    Benzinga
  29. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  30. QIAGEN Announces Partnership With Clovis Oncology to Co-develop ...

    Benzinga
  31. Mid-Day Market Update: Dow Falls Over 100 Points; Active Network ...

    Benzinga
  32. Mid-Morning Market Update: Markets Open Lower; Cal-Maine Q1 Net ...

    Benzinga
  33. Mid-Day Market Update: US Stocks Turn Higher; MAKO Surgical Shares ...

    Benzinga
  34. Mid-Morning Market Update: Markets Slip; AutoZone Q4 Net Profit ...

    Benzinga
  35. Morning Market Losers

    Benzinga
  36. Benzinga's M&A Chatter for Tuesday September 24, 2013

    Benzinga
  37. Benzinga's Top Initiations

    Benzinga
  38. Benzinga's M&A Chatter for Tuesday September 17, 2013

    Benzinga
  39. UPDATE: Stifel Initiates Coverage on Clovis Oncology, Awaiting ...

    Benzinga
  40. These ETFs House The Next Biotech Takeover Targets

    Benzinga
  41. Mid-Day Market Update: Markets Slow Their Rally; JC Penney Spikes ...

    Benzinga
  42. Mid-Morning Market Update: Markets Continue Cautious Rally; Jefferies ...

    Benzinga
  43. Benzinga's Top Pre-Market Losers

    Benzinga
  44. Health Care Sector Wrap

    FoxBusiness
  45. Health Care Sector Wrap

    FoxBusiness
  46. Clovis Oncology and Array BioPharma Announce Agreement to Discover ...

    Benzinga
  47. Clovis Oncology Announces FDA Acceptance of Investigational New ...

    Benzinga
  48. End-of-Day Market Summary for January 18, 2012

    Benzinga
  49. UPDATE: JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  50. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  51. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
Trading Center